Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive‐stage small cell lung cancer: Two case reports.

MLA

Watari, Naokazu, et al. “Tolerability and Efficacy of IMpower133 Regimen Modified for Dialysis Patients with Extensive‐stage Small Cell Lung Cancer: Two Case Reports.” Thoracic Cancer, vol. 12, no. 21, Nov. 2021, pp. 2956–60. EBSCOhost, https://doi.org/10.1111/1759-7714.14166.

APA

Watari, N., Yamaguchi, K., Masuda, T., Ito, N., Sakamoto, S., Horimasu, Y., Miyamoto, S., Nakashima, T., Iwamoto, H., Fujitaka, K., Hamada, H., & Hattori, N. (2021). Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive‐stage small cell lung cancer: Two case reports. Thoracic Cancer, 12(21), 2956–2960. https://doi.org/10.1111/1759-7714.14166

Chicago

Watari, Naokazu, Kakuhiro Yamaguchi, Takeshi Masuda, Noriaki Ito, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, et al. 2021. “Tolerability and Efficacy of IMpower133 Regimen Modified for Dialysis Patients with Extensive‐stage Small Cell Lung Cancer: Two Case Reports.” Thoracic Cancer 12 (21): 2956–60. doi:10.1111/1759-7714.14166.